EPISALVAN

This brand name is authorized in Estonia, Poland.

Active ingredients

The drug EPISALVAN contains one active pharmaceutical ingredient (API):

1	Betulin UNII 3R504894L9 - BETULA PUBESCENS BARK
	Betulin accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 μg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 µg/ml. The precise mechanism of action of the active substance in wound healing in humans is not known.
	Read more about Betulin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EPISALVAN Gel	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D03AX13		D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1708668
PL	Rejestru Produktów Leczniczych	100362898